First Time Loading...

China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294

Watchlist Manager
China Resources Boya Bio pharmaceutical Group Co Ltd Logo
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Watchlist
Price: 31.28 CNY -0.29% Market Closed
Updated: Apr 29, 2024
China Resources Boya Bio pharmaceutical Group Co Ltd
/
Income Statement
/
Net Income (Common)

China Resources Boya Bio pharmaceutical Group Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

China Resources Boya Bio pharmaceutical Group Co Ltd
Net Income (Common) Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Net Income (Common)
¥237.5m
CAGR 3-Years
-3%
CAGR 5-Years
-13%
CAGR 10-Years
11%
Beigene Ltd
HKEX:6160
Net Income (Common)
-¥13.6B
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Net Income (Common)
-¥1B
CAGR 3-Years
-1%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Net Income (Common)
¥1.2B
CAGR 3-Years
23%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Net Income (Common)
¥8.5B
CAGR 3-Years
40%
CAGR 5-Years
47%
CAGR 10-Years
45%
Imeik Technology Development Co Ltd
SZSE:300896
Net Income (Common)
¥1.3B
CAGR 3-Years
61%
CAGR 5-Years
73%
CAGR 10-Years
N/A

See Also

What is China Resources Boya Bio pharmaceutical Group Co Ltd's Net Income (Common)?
Net Income (Common)
237.5m CNY

Based on the financial report for Dec 31, 2023, China Resources Boya Bio pharmaceutical Group Co Ltd's Net Income (Common) amounts to 237.5m CNY.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
11%

Over the last year, the Net Income (Common) growth was -45%. The average annual Net Income (Common) growth rates for China Resources Boya Bio pharmaceutical Group Co Ltd have been -3% over the past three years , -13% over the past five years , and 11% over the past ten years .

ALPHA SPREAD
Join more than 132,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.